Wed, Jul 26|
Julie Grant is a General Partner at Canaan, a tech and healthcare venture capital fund with $5B assets under management.
She leads investments in biopharma and digital health companies. Since joining Canaan in 2013, she has incubated, financed, and supported investments in more than 12 biopharmaceutical companies. Prior to Canaan, Julie worked at Genentech, bringing new oncology products to the market.
Time & Location
Jul 26, 2023, 2:00 PM EDT
About The Event
Julie Grant is a General Partner at Canaan, a tech and healthcare venture capital fund with $5B assets under management. She leads investments and company formation efforts in biopharma and digital health companies that tangibly improve patient care. Since joining Canaan in 2013, Julie has incubated, financed, and supported investments in multiple new biopharmaceutical companies including Day One (DAWN), Nocion, Synthekine, Protagonist (PTGX), Cellular Research (Acquired by Becton Dickinson), Dermira (Acquired by Eli Lilly), Labrys (Acquired by Teva), CytomX (CTMX), Unchained Labs (Acquired by The Carlyle Group), Genome Medical, Glooko, and Truveris.
Prior to joining Canaan, Julie worked at Genentech bringing new oncology products to market in roles spanning business development, cross functional management and commercial. She holds an M.B.A. from Stanford’s Graduate School of Business, a M.Phil. from Cambridge University in BioScience Enterprise and a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Our conversations take place over a Zoom call, not a webinar, so there is space to share experiences and ask for advice. The event will be carried out as a fireside chat for 30 minutes plus a 20 minute Q&A.